483
AlloSourceAlloSource – FDA 483, Mar 30, 2023
Record Details
An FDA inspection of AlloSource in Centennial, CO, revealed significant deficiencies in process validation for several human tissue allograft products, including PureSkin ™ XL, AlloWrap DS, and AlloWrap Dry. The firm failed to validate processing steps to prevent contamination and the spread of communicable diseases. Additionally, the facility's gowning room and adjacent locker room were not maintained in a clean and sanitary manner, posing further risks of contamination.
View Company Profile
ID · 1db928f1-d988-4de3-9463-71ef1b113f4b
Other documents for AlloSource
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.